Alexander Marson, MD, PhD
Alex Marson is Director of the Gladstone-UCSF Institute of Genomic Immunology, and Associate Professor in the UCSF Department of Medicine. The Marson Lab is pioneering new CRISPR gene editing technologies that offer faster, cheaper and more precise ways to re-write DNA programs in human immune cells. With these tools, the lab is probing genetic underpinnings of type 1 diabetes and other immune-mediated diseases and engineering new cellular immunotherapies.
Marson attended college and medical school at Harvard. He received a master’s degree in Biological Sciences from Cambridge University and a PhD in Biology from MIT. Marson was a resident at the Brigham and Women’s Hospital, and completed clinical training in Infectious Diseases at UCSF. He started his lab as a UCSF Sandler Faculty Fellow in 2013. Marson is the scientific director for Human Health at the Innovative Genomics Institute (IGI). He is a member of the Parker Institute for Cancer Immunotherapy and was selected as one of the inaugural Chan Zuckerberg Biohub investigators.